Drugs / CZ48
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02575638 | Jul 2008 → Oct 2019 | cancer, lymphoma | Cao Pharmaceuticals Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CZ48 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02575638 ↗ |
| Route | Oral | “CZ48 will be administered orally daily” NCT02575638 ↗ |